Treatment

White House Targets Hepatitis C Eradication: Public Health Labs Key in Treatment

The 2024 White House budget proposes eradicating Hepatitis C virus (HCV) within five years, utilizing highly effective direct-acting antiviral (DAA) therapies. Despite their availability for…

Geraldine Joseph,

MPH, RPA-C, AAHIVM
Samaritan DayTop Village

Patient Management Guidelines

Articles

Integrated HCV Treatment Shows Limited Impact on Psychological Distress in Substance Use Disorder Patients

A recent study examined the impact of integrated hepatitis C virus (HCV) treatment on psychological distress among individuals with substance...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Cost-Effectiveness Analysis for Hepatitis C Treatment

Are direct-acting antivirals for the treatment of hepatitis C virus (HCV) more effective than peginterferon alfa and ribavirin (PEG/riba)? Researchers...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

Hepatitis C Evolution: From IFN Treatments to DAAs and Future Vaccine Research

This comprehensive overview of hepatitis C virus (HCV) infection includes its treatment history, genetic factors, resistance issues, and future research...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

New Report Urges Single-Visit Hepatitis C Testing to Improve Diagnosis and Treatment Outcomes

A report highlights the need to update hepatitis C virus (HCV) testing protocols for better diagnosis and treatment. Currently, about...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Review Emphasizes Antiviral Therapy’s Role in HCV Treatment, SVR Achievement, and Improved Health Outcomes

A recent review focused on treating the hepatitis C virus (HCV) to achieve a sustained virologic response (SVR), considered a...